Chemed Corp
Organization details
- Legal name
- Chemed Corp
- Former names
- Roto-Rooter Inc
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 8082 — Services-Home Health Care Services
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Cincinnati
- Headquarters state / province
- Ohio
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- CHE
- Primary stock exchange
- NYSE
Identifiers
- SEC CIK
- 0000019584
- EIN
- 31-0791746
- Wikidata ID
- Q106241500
Board of directors
-
Andrea R. Lindell · DirectorSince 2023
-
Christopher J. Heaney · DirectorSince 2023
-
Eileen P. McCarthy · DirectorSince 2023
-
George J. Walsh III · DirectorSince 2023
-
John Meredith Mount Jr. · DirectorSince 2023
-
Kevin J. Mcnamara · Director · president and CEOSince 2023
-
Patrick P. Grace · DirectorSince 2023
-
Ron DeLyons · DirectorSince 2023
-
Thomas C. Hutton · Director · vice presidentSince 2023
-
Thomas P. Rice · DirectorSince 2023
Chief executives
Director election results
Annual meeting of May 18, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
82.8%
-
88.4%
-
94.1%
-
96.3%
-
97.7%
-
98.2%
-
98.8%
-
99.4%
-
99.5%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $10,327,947
- 15 sales by 5 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 3, 2026 | Kevin J. Mcnamara Director, Officer (president and CEO) | Open-market sale | −2,000 | $537.90 | $1,075,800 |
| Nov 2, 2026 | LEE SPENCER S Officer (executive vice president) | Open-market sale | −920 | $537.17 | $494,196 |
| Sep 30, 2026 | LEE SPENCER S Officer (executive vice president) | Option exercise | +12,099 | $445.35 | $5,388,290 |
| Sep 30, 2026 | LEE SPENCER S Officer (executive vice president) | Shares withheld for tax | −11,160 | $508.93 | $5,679,659 |
| Sep 28, 2026 | Thomas C. Hutton Director, Officer (vice president) | Option exercise | +4,629 | $445.35 | $2,061,525 |
| Sep 28, 2026 | Kevin J. Mcnamara Director, Officer (president and CEO) | Open-market sale | −2,000 | $513.45 | $1,026,900 |
| Sep 28, 2026 | Thomas C. Hutton Director, Officer (vice president) | Shares withheld for tax | −4,270 | $506.65 | $2,163,396 |
| Sep 18, 2026 | Kevin J. Mcnamara Director, Officer (president and CEO) | Open-market sale | −2,000 | $501.40 | $1,002,800 |
| Aug 21, 2026 | Kevin J. Mcnamara Director, Officer (president and CEO) | Open-market sale | −2,000 | $541.16 | $1,082,320 |
| Aug 21, 2026 | LEE SPENCER S Officer (executive vice president) | Open-market sale | −1,000 | $541.04 | $541,040 |
| Aug 10, 2026 | Judkins Brian C Officer (VP and Chief Legal Officer) | Option exercise | +6,786 | $445.35 | $3,022,145 |
| Aug 10, 2026 | Judkins Brian C Officer (VP and Chief Legal Officer) | Shares withheld for tax | −5,878 | $548.96 | $3,226,787 |
| Aug 5, 2026 | Wherley Joel L Officer (CEO - Vitas Healthcare) | Option exercise | +2,599 | $445.35 | $1,157,465 |
| Aug 5, 2026 | Wherley Joel L Officer (CEO - Vitas Healthcare) | Shares withheld for tax | −2,270 | $542.62 | $1,231,747 |
| Aug 3, 2026 | Kevin J. Mcnamara Director, Officer (president and CEO) | Open-market sale | −2,000 | $539.51 | $1,079,020 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Chemed Corp
Who is the CEO of Chemed Corp?
Kevin J. Mcnamara is Chemed Corp's president and CEO.
How many directors are on Chemed Corp's board?
Chemed Corp's board has 10 directors: Andrea R. Lindell, Christopher J. Heaney, Eileen P. McCarthy, George J. Walsh III, John Meredith Mount Jr., Kevin J. Mcnamara, Patrick P. Grace, Ron DeLyons, Thomas C. Hutton and Thomas P. Rice.
Are Chemed Corp insiders buying or selling shares?
Over the last 12 months, Chemed Corp insiders made no open-market purchases and sold $10.3 million of shares in 15 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="chemed-corp"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.